Menu Search
Equities

AnaptysBio Inc

AN6:MUN

AnaptysBio Inc

Actions
  • Price (EUR)33.40
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change+90.86%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 07:01 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year AnaptysBio Inc had net income fall 27.11% from a loss of 128.72m to a larger loss of 163.62m despite a 66.78% increase in revenues from 10.29m to 17.16m.
Gross margin--
Net profit margin-558.25%
Operating margin-532.89%
Return on assets-36.02%
Return on equity-214.89%
Return on investment-39.45%
More ▼

Cash flow in USDView more

In 2023, cash reserves at AnaptysBio Inc fell by 35.34m. However, Cash Flow from Investing totalled 144.75m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 120.80m for operations while cash used for financing totalled 59.30m.
Cash flow per share-6.32
Price/Cash flow per share--
Book value per share0.3601
Tangible book value per share0.3601
More ▼

Balance sheet in USDView more

AnaptysBio Inc uses little or no debt in its capital structure.
Current ratio9.09
Quick ratio--
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.